Liquid biopsy and multiparametric analysis in management of liver malignancies: new concepts of the patient stratification and prognostic approach

[1]  Ya Cao,et al.  Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma , 2018, Annals of Surgical Oncology.

[2]  Yun Zhang,et al.  Protein S100-A8: A potential metastasis-associated protein for breast cancer determined via iTRAQ quantitative proteomic and clinicopathological analysis. , 2018, Oncology letters.

[3]  M. Hofmann-Apitius,et al.  Multi-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicine , 2018, Amino Acids.

[4]  G. Duarte,et al.  Capacity to report on mortality attributable to chronic hepatitis B and C infections by Member States: An exercise to monitor progress towards viral hepatitis elimination , 2018, Journal of viral hepatitis.

[5]  F. Piñero,et al.  Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina , 2018, World journal of hepatology.

[6]  M. Hofmann-Apitius,et al.  Multi-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicine , 2017, Amino Acids.

[7]  D. Hayes,et al.  Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome , 2017, Breast Cancer Research and Treatment.

[8]  K. Guo,et al.  Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization , 2017, Medicine.

[9]  Dong-hao Wu,et al.  Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma , 2017, Oncology letters.

[10]  Y. Soini,et al.  Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy , 2017, Oxidative medicine and cellular longevity.

[11]  J. Rowe,et al.  Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis , 2017, Journal of carcinogenesis.

[12]  X. Zhang,et al.  Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients , 2017, Medicine.

[13]  E. Winer,et al.  Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population-Based Study. , 2017, The oncologist.

[14]  Milena Kralickova,et al.  Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon? , 2017, EPMA Journal.

[15]  O. Golubnitschaja.  Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification? , 2017, The EPMA Journal.

[16]  Hans H Schild,et al.  Breast cancer risk assessment: a non-invasive multiparametric approach to stratify patients by MMP-9 serum activity and RhoA expression patterns in circulating leucocytes , 2016, Amino Acids.

[17]  M. Fujino,et al.  Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization , 2016, Oncology.

[18]  Rostyslav V Bubnov,et al.  Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016 , 2016, EPMA Journal.

[19]  O. Negm,et al.  SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells , 2016, Oncotarget.

[20]  O. Golubnitschaja,et al.  Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes , 2016, Clinical & Experimental Metastasis.

[21]  W. Kuhn,et al.  Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures , 2016, Tumor Biology.

[22]  Z. Zeng,et al.  S100A8 facilitates the migration of colorectal cancer cells through regulating macrophages in the inflammatory microenvironment. , 2016, Oncology reports.

[23]  N. Novak,et al.  Cellular Distribution and Gene Expression Pattern of Metastasin (S100A4), Calgranulin A (S100A8), and Calgranulin B (S100A9) in Oral Lesions as Markers for Molecular Pathology , 2016, Cancer investigation.

[24]  H. Schild,et al.  Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours , 2016, BMC Cancer.

[25]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[26]  A. Mokdad,et al.  Advances in Local and Systemic Therapies for Hepatocellular Cancer , 2016, Current Oncology Reports.

[27]  P. Schirmacher,et al.  A pro-tumorigenic function of S100A8/A9 in carcinogen-induced hepatocellular carcinoma. , 2015, Cancer letters.

[28]  J. Bae,et al.  Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. , 2015, Cytokine.

[29]  Subodh Kumar Jain,et al.  Molecular Links between Alcohol and Tobacco Induced DNA Damage, Gene Polymorphisms and Patho-physiological Consequences: A Systematic Review of Hepatic Carcinogenesis. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[30]  Nobhojit Roy,et al.  The Global Burden of Cancer 2013. , 2015, JAMA oncology.

[31]  Rostyslav V Bubnov,et al.  EPMA position paper in cancer: current overview and future perspectives , 2015, EPMA Journal.

[32]  I. Vrabas,et al.  Blood reflects tissue oxidative stress: a systematic review , 2015, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[33]  R. Idilman,et al.  Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy , 2014, Annals of Nuclear Medicine.

[34]  Chien-Wei Chang,et al.  Involvement of DNA Damage Response Pathways in Hepatocellular Carcinoma , 2014, BioMed research international.

[35]  M. Kudo,et al.  Oxidative Stress and Epigenetic Instability in Human Hepatocarcinogenesis , 2013, Digestive Diseases.

[36]  O. Mir,et al.  Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo , 2012, Molecular Cancer Therapeutics.

[37]  M. Marra,et al.  Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview , 2011, Journal of Translational Medicine.

[38]  P. Schirmacher,et al.  S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis , 2009, Hepatology.

[39]  Yasuhiro Ito,et al.  S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. , 2008, Current cancer drug targets.

[40]  A. Ananthakrishnan,et al.  Epidemiology of primary and secondary liver cancers. , 2006, Seminars in interventional radiology.

[41]  O. Golubnitschaja,et al.  DNA damage and expression of checkpoint genes p21WAF1/CIP1 and 14-3-3 σ in taurine-deficient cardiomyocytes , 2003 .

[42]  B. Stewart,et al.  World Cancer Report , 2003 .

[43]  C. Decker,et al.  Altered gene expression in lymphocytes of patients with normal-tension glaucoma , 2000, Current eye research.

[44]  K. Hess,et al.  Unknown primary tumors metastatic to liver. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  O. Golubnitschaja,et al.  DNA damage and expression of checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in taurine-deficient cardiomyocytes. , 2003, Biochemical pharmacology.

[46]  Xiaomei Ma,et al.  Global Burden of Cancer , 2006, The Yale journal of biology and medicine.